Related Experiment Video
Updated: Apr 4, 2026
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
16.3K
Pitfalls and Challenges to Consider before Setting up a Lung Cancer Intensity-modulated Radiotherapy Service: A
R K Shrimali1, A Mahata2, G D Reddy1
1Department of Radiation Oncology, Tata Medical Center, Kolkata, India.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|September 3, 2015
Summary
Intensity-modulated radiotherapy (IMRT) shows potential benefits for non-small cell lung cancer (NSCLC) treatment by reducing lung toxicity. However, caution is advised due to motion challenges and limited prospective data on its efficacy and safety.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Intensity-modulated radiotherapy (IMRT) is increasingly adopted for non-small cell lung cancer (NSCLC) without randomized controlled trials.
- Studies suggest IMRT may reduce lung toxicity predictors (V20, mean lung dose) and spinal cord dose.
Purpose of the Study:
- To review the application of IMRT in NSCLC.
- To address the challenges and highlight potential benefits of IMRT for NSCLC.
Main Methods:
- Review of existing planning studies and retrospective series on IMRT for NSCLC.
- Analysis of dosimetric advantages and potential challenges.
Main Results:
- IMRT may decrease lung V20 and mean lung dose, and maximum spinal cord dose.
- Challenges include organ/tumor motion due to breathing and potential toxicity from irradiating larger lung volumes.
Conclusions:
- IMRT offers potential dosimetric advantages for NSCLC but may not suit all patients.
- Paucity of prospective data necessitates caution; IMRT data from other sites should not be extrapolated.
